Capricor Therapeutics Inc. (CAPR)
NASDAQ · Healthcare
Capricor Therapeutics Inc. Net Income 2011–2025
Capricor Therapeutics Inc. annual/quarterly net income history and growth rate from 2011 to 2024. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Capricor Therapeutics Inc. net income for the quarter ending September 30, 2024 was -12.6 M, a 96.49% increase year-over-year.
- Capricor Therapeutics Inc. net income for the twelve months ending September 30, 2024 was -39.7 M, a 51.37% increase year-over-year.
- Capricor Therapeutics Inc. annual net income for 2025 was -105.0 M, a 159.58% increase from 2024.
- Capricor Therapeutics Inc. annual net income for 2024 was -40.5 M, a 81.57% increase from 2023.
- Capricor Therapeutics Inc. annual net income for 2023 was -22.3 M, a 23.20% decrease from 2022.
- Capricor Therapeutics Inc. annual net income for 2022 was -29.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Capricor Therapeutics Inc. Net Income — FAQ
Capricor Therapeutics Inc. (CAPR) net income over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
What is Capricor Therapeutics Inc.'s net income?
Capricor Therapeutics Inc. (CAPR) reported net income of -$105M for fiscal 2025.
Where can I see CAPR's net income history?
The chart and table above show Capricor Therapeutics Inc.'s net income by year and by quarter, including the growth rate.